OPKO Health, Inc. Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
OPKO Health, Inc. (OPK) had Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit of $0 as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit · last filed 2025-03-03
- 2024-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2023-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2022-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2021-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $3.20M.
| Period end | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-01 |
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 |
| 2021-12-31 | $3.20M 10-K · filed 2022-03-01 |
| 2020-12-31 | $1.50M 10-K · filed 2021-02-18 |
| 2019-12-31 | $500.00K 10-K · filed 2020-03-02 |
| 2018-12-31 | $1.30M 10-K · filed 2019-03-01 |
| 2017-12-31 | $4.60M 8-K · filed 2019-01-29 |
| 2016-12-31 | $4.10M 10-K · filed 2017-03-01 |
| 2015-12-31 | $100.00K 10-K · filed 2016-02-29 |
| 2014-12-31 | $900.00K 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |